Yearly Archives: 2026

/2026

Drug Tariff Watch – February 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – February 2026 appeared first on Community Pharmacy England.

By |January 28th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – February 2026

Pharmacies deserve better – end the unfair disparity in business rates relief

In response to the government announcement that all pubs and live music venues will benefit from a 15% business rates relief, with bills also being frozen in real terms for a further two years, we have released the following statement to the press: Our CEO Janet Morrison said: “Unlike GP practices and dental surgeries, the [...]

The post Pharmacies deserve better – end the unfair disparity in business rates relief appeared first on Community Pharmacy England.

By |January 28th, 2026|Lexpos News|Comments Off on Pharmacies deserve better – end the unfair disparity in business rates relief

MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd)

MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) Drug alert number: EL(26)A/04 Date issued: 28 January 2026 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle. DMRC reference number:DMRC-38220370 Marketing [...]

The post MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) appeared first on Community Pharmacy England.

By |January 28th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd)

Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches. MSN/2026/004 Tier 2 – Medium impact Date of issue: 28 January 2026 Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches are out of stock until late-February 2026. Oxybutynin 5mg and 10mg modified-release tablets remain available and can support increased [...]

The post Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches appeared first on Community Pharmacy England.

By |January 28th, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches

FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated

Update 06/02/2026: Updated to include additional products/batches: Product Batch code Expiry Aptamil First Infant Formula (800 g) All dates from 9 July 2026 to 4 December 2026 All dates from 9 July 2026 to 4 December 2026 Aptamil First Infant Formula (700 g) All dates from 22 August 2026 to 26 November 2026 All dates from 22 [...]

The post FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated appeared first on Community Pharmacy England.

By |January 27th, 2026|Lexpos News|Comments Off on FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated